Effectiveness of Vibrapep (OPEP) on Pulmonary functions in phase one of cardiac rehabilitatio
Phase 2
Completed
- Conditions
- Health Condition 1: I519- Heart disease, unspecified
- Registration Number
- CTRI/2023/10/058856
- Lead Sponsor
- KAHER Institute of physiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 46
Inclusion Criteria
1.Participants aged between 30 to 75 years of age of all gender.
2.Subjects having stable vitals following CABG and Valve replacement surgery.
3.Participants of phase 1 cardiac rehabilitation.
4.Who are willing to participate
Exclusion Criteria
1.Participants who are uncooperative.
2.Hemodynamic instability.
3.Participants unable to understand or use the device appropriately.
4.Active respiratory tract infection (COPD, acute bronchitis, Restrictive Lung Disease etc.)
5.Patients who are on prolonged mechanical ventilation.
6.Subjects Who are critically ill and with systemic illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Thoracic expansion measurement <br/ ><br>2.peak flow meter <br/ ><br>3.maximal expiratory and inspiratory pressure manometer <br/ ><br>4.sputum volume <br/ ><br>Timepoint: pre and post assessment will be taken. Pre assessment will be done day 1 and post assessment will be done on day 5. <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. Blood pressure measurement <br/ ><br>2. SPO2 Level measurementTimepoint: pre and post assessment will be taken. Pre assessment will be done day 1 and post assessment will be done on day 5.